Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Aging (Albany NY) ; 14(10): 4195-4210, 2022 05 23.
Article in English | MEDLINE | ID: covidwho-1863474

ABSTRACT

Previous studies have shown that the polyamine spermidine increased the maximum life span in C. elegans and the median life span in mice. Since spermidine increases autophagy, we asked if treatment with chloroquine, an inhibitor of autophagy, would shorten the lifespan of mice. Recently, chloroquine has intensively been discussed as a treatment option for COVID-19 patients. To rule out unfavorable long-term effects on longevity, we examined the effect of chronic treatment with chloroquine given in the drinking water on the lifespan and organ pathology of male middle-aged NMRI mice. We report that, surprisingly, daily treatment with chloroquine extended the median life span by 11.4% and the maximum life span of the middle-aged male NMRI mice by 11.8%. Subsequent experiments show that the chloroquine-induced lifespan elevation is associated with dose-dependent increase in LC3B-II, a marker of autophagosomes, in the liver and heart that was confirmed by transmission electron microscopy. Quite intriguingly, chloroquine treatment was also associated with a decrease in glycogenolysis in the liver suggesting a compensatory mechanism to provide energy to the cell. Accumulation of autophagosomes was paralleled by an inhibition of proteasome-dependent proteolysis in the liver and the heart as well as with decreased serum levels of insulin growth factor binding protein-3 (IGFBP3), a protein associated with longevity. We propose that inhibition of proteasome activity in conjunction with an increased number of autophagosomes and decreased levels of IGFBP3 might play a central role in lifespan extension by chloroquine in male NMRI mice.


Subject(s)
Autophagy , Chloroquine , Glycogenolysis , Longevity , Proteasome Endopeptidase Complex , Proteasome Inhibitors , Animals , Autophagy/drug effects , Chloroquine/pharmacology , Glycogen , Glycogenolysis/drug effects , Longevity/drug effects , Male , Mice , Proteasome Inhibitors/pharmacology , Spermidine/pharmacology , COVID-19 Drug Treatment
2.
Rom J Morphol Embryol ; 61(1): 209-218, 2020.
Article in English | MEDLINE | ID: covidwho-693877

ABSTRACT

We are reporting a case of natural evolution and pathological data from a young person that was diagnosed with coronavirus disease 2019 (COVID-19). All data has been collected from the autopsy of a 30-year-old female, which was performed by the Department of Forensic Medicine from Emergency County Hospital, Drobeta Turnu Severin, Mehedinti County, Romania. The infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was confirmed by reverse transcription polymerase chain reaction (RT-PCR) on the lung tissue which was obtained during autopsy. This case provides the opportunity to study the natural evolution of COVID-19 pneumonia in a young person with clinical signs of pneumonia but without associated comorbidities. The patient had not received any treatment. The histopathological examination of the lung revealed a process of productive proliferation, proteinaceous and fibrin-macrophagic interalveolar spaces exudate, and lesions consistent with vasculitis. In the heart, we identified a cardiac thrombus. These changes are likely to suggest an advanced natural evolution of SARS-CoV-2 virus infection.


Subject(s)
Coronavirus Infections/physiopathology , Coronavirus Infections/virology , Lung/virology , Pneumonia, Viral/physiopathology , Pneumonia, Viral/virology , Adult , Autopsy , Betacoronavirus , COVID-19 , COVID-19 Testing , Clinical Laboratory Techniques , Coronavirus Infections/diagnosis , Female , Humans , Kidney/pathology , Liver/pathology , Lung/pathology , Myocardium/pathology , Pancreas/pathology , Pandemics , Reverse Transcriptase Polymerase Chain Reaction , Romania , SARS-CoV-2 , Thrombosis/pathology , Thrombosis/virology
SELECTION OF CITATIONS
SEARCH DETAIL